Yazar "Güven, Eşref Oğuz" seçeneğine göre listele
Listeleniyor 1 - 4 / 4
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Hemorajik kist ile birlikte prostat adenokarsinoması: Olgu sunumu ve yayınların gözden geçirilmesi(2006) Görür, Sadık; Balcı, Ali; Karazincir, Sinem; Güven, Eşref Oğuz; Sumbas, Haldun; Kiper, Ahmet NamıkProstat adenokarsinomu ile birlikte hemorajik kist formasyonu ender görülen bir durumdur. Çoğunlukla alt üriner sistem belirtileri (AÜSB) ile üroloji polikliniğine başvuran ve tetkik edilen hastalarda rastlantısal olarak tespit edilir. Bu olguda AÜSS semptomları ile üroloji polikliniğine başvuran ve serum prostat-spesifik antijen düzeyi 102.35 ng/ml saptanan bir olguyu sundukÖğe The impact of NIH-IV prostatitis on early post-operative outcomes of transurethral resection of the prostate in patients with symptomatic benign prostate hyperplasia(2011) Yalçınkaya, Fatih Rüştü; Gökçe, Ahmet; Davarcı, Mürsel; Güven, Eşref Oğuz; İnci, Mehmet; Kartal, Süleyman Barış; Ayyıldız, Ali; Balbay, Mevlana DeryaAim: Transurethral prostate resection (TURP) is still considered the gold standard in the treatment of symptomatic benign prostate hyperplasia (BPH). Category IV chronic prostatitis (CP) is described by the National Institute of Health (NIH-IV) as the asymptomatic infl ammation of the prostate and it may be detected along with benign prostate hyperplasia (BPH) during histological examinations of the prostate. In this study, we evaluate the impact of the presence of NIH-IV defi ned prostatitis on early post-operative outcomes of transurethral resection of the prostate. Materials and methods: Between 2004 and 2008, medical records of 247 patients who underwent TURP in Adana Numune Training and Research hospital were examined, retrospectively. Patients who had a histological diagnosis of only BPH were considered in Group 1 whereas Group 2 consisted of patients with both NIH-IV CP and BPH simultaneously. Factors such as total prostate specifi c antigen (tPSA) levels, International Prostate Symptom Scores (IPSS), singlequestion quality of life (QoL) assessments, maximum fl ow rates (Q max), residual urine volumes, catheterization times, re-catheterization rates, and the duration of re-catheterization were compared between these 2 groups. IPSS, QoL, and urofl owmetry measurements were compared between the 2 groups again at the third post-operative month. Statistical analysis with Student’s t and chi-square tests was performed with SPSS ® version 16. Results: Preoperatively, no statistically signifi cant diff erence was present between the 2 groups with respect to IPSS, Q max, QoL, prostate volume, tPSA, and mean catheterization time (P > 0.05); however, re-catheterization rates were signifi cantly diff erent (P < 0.05). While meaningful diff erence was found between 90th day IPSS and QoL medians (P < 0.05), there was no diff erence in Q max medians (P > 0.05). Conclusion: NIH-IV chronic prostatitis shows negative eff ects on the subjective post-operative results and recatheterization frequency of BPH patients that have undergone TURP.Öğe Penile Mondor's disease can be effectively treated with the use of an acetyl salicylic acid and pentoxifylline combination(2010) Davarcı, Mürsel; Güven, Eşref Oğuz; Gökçe, Ahmet; Yalçınkaya, Fatih Rüştü; Kiper, Ahmet Namık; Balbay, Mevlana DeryaAbstract: Since penile Mondor's disease is a rare condition, different treatment choices are used. Herein we recommend a new treatment strategy with acetylsalicylic acid and pentoxifylline, which was tested in 14 patients with penile Mondor's disease. Materials and methods: Fourteen patients with the clinical presentation of penile Mondor's disease were included. Patients were given acetylsalicylic acid (ASA) 500 mg qid and pentoxifylline 600 mg bid for 14 days. Physical examinations were performed in all patients. In addition, ultrasonic examinations were done before the treatment and on days 7 and 14 of treatment to evaluate dorsal vein thrombosis. Results: Physical examinations revealed lesions parallel to the coronal sulcus in 9 patients and in the dorsal aspect of the proximal penis in 5 patients. All patients had painful induration of the penis. On day 7, hyperechoic structures were still observed in 8 patients and no thrombus was seen in 6 patients. Ultrasonographic measurements were repeated 14 days after treatment and a hyperechoic structure was observed in 4 patients. No side effects were encountered during the follow-up period. Conclusion: We think that the ASA and pentoxifylline protocol, which is also used for the treatment of thrombotic events in other parts of the body, helps to resolve penile Mondor's disease in a shorter time compared to previous treatment protocols. Further randomized controlled studies are needed for a definitive decision.Öğe Urodynamic evaluation of acute effects of sildenafi l on voiding among males with erectile dysfunction and symptomatic benign prostate(2012) Yalçınkaya, Fatih Rüştü; Davarcı, Mürsel; Akçin, Soner; Gökçe, Ahmet; Güven, Eşref Oğuz; İnci, Mehmet; Balbay, Mevlana DeryaAim: To evaluate the acute eff ects of sildenafi l citrate on micturition of men with erectile dysfunction and symptomatic benign prostatic hyperplasia using urodynamic parameters. Materials and methods: Between June and December 2009, a total of 50 patients over the age of 40 participated in the study. Th e patients were admitted to our hospital with erectile dysfunction and moderate to severe lower urinary symptoms with benign prostatic hyperplasia. To examine the sexual function of the participants, we used the IIEF-5 Sexual Health Inventory for Men questionnaire. Patients were randomly divided into 2 groups: a treatment group and a control group. A basal urodynamic evaluation was performed in both groups. Aft er the urodynamic evaluation, 50 mg of sildenafi l was given to the patients in the control group and 1 h later a second evaluation was performed. Following the urodynamic evaluation, a placebo was given to the patients in the control group and then a second evaluation was performed aft er 1 h. Results: A statistically signifi cant increase was seen in maximal fl ow and average fl ow (Qmax and Qave) aft er 1 hin the treatment group. Th e increase in the control group was not signifi cant. Conclusion: Based on the study fi ndings, we suggest that sildenafi l has an eff ect on micturition in the short term. However, to determine the role of sildenafil in the treatment of BPH/LUTS, further studies with larger patient groups are needed.
